CHICAGO (Reuters) – Johnson & Johnson said on Thursday it will start adding the price of its medicines to television commercials by next month, becoming the first drugmaker to heed a call by U.S. President Donald Trump for price transparency of drugs advertised directly to consumers on TV.
The healthcare conglomerate said it will include both the list price of a product – the price before any rebates or discounts to insurers or pharmacy benefit managers – as well as potential out-of-pocket costs that patients will pay.
Move - Statement - J - J - Website
The move, announced in a statement on J&J’s website, won swift praise from U.S. Health and Human Services Secretary Alex Azar. Last May, Azar’s office released a blueprint for reducing the cost of drug prices, which included a proposal to require disclosure of list prices in TV ads for drugs.
“We commend Johnson & Johnson for recognizing the value of informing consumers about list prices and for doing...
Wake Up To Breaking News!
It is time to put away the our toys and propaganda we've been taught as children and think for ourselves.